P473. Antibodies to infliximab, body weight and low serum albumin levels increase clearance of infliximab, a population pharmacokinetic study in 324 IBD patients | Zendy

AI Assistant Blog Pricing

P473. Antibodies to infliximab, body weight and low serum albumin levels increase clearance of infliximab, a population pharmacokinetic study in 324 IBD patients

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.